Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

AI and Sequential Organ Failure Assessment

AI Biotech/Diagnostics: Other Innovation Patent Forecast®

August 29, 2019

Peach IntelliHealth is a New York based Artificial Intelligence & Machine Learning (AI/ML) healthcare company. Founded by five MIT scientists, their product Peach ACE is used to predict patient trajectory hours before measurable signals. The company was founded in 2013 and has yet to take a major funding round, though it is currently seeking synergistic partners. Peach IntelliHealth recently filed their first patent application for their technology, which could point to a desire to increase valuation in order to bring in capital to scale.


Relevant Patent Documents

Application US20190259499  

Article Source Link

Peach IntelliHealth


View Patent Forecast®

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.

AI Biotech/Diagnostics: Other Innovation   Patent Forecast®

View Patent Forecast® Top Corporations News and Insights Data Visualization

Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.



301